Magnetic Resonance Imaging for Stage IV Melanoma During Pregnancy—Reply
In the United Kingdom, the National Radiological Protection Board (NRPB), now the Radiation Protection Division of the Health Protection Agency, suggests that pregnant women should not be offered MRI in the first 3 months of pregnancy. These, in turn, can cause adverse effects that may be avoidable...
Gespeichert in:
| Veröffentlicht in: | Archives of dermatology (1960) 2006-03, Vol.142 (3), p.393-403 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 403 |
|---|---|
| container_issue | 3 |
| container_start_page | 393 |
| container_title | Archives of dermatology (1960) |
| container_volume | 142 |
| creator | Beyeler, Mirjam Hafner, Jürg |
| description | In the United Kingdom, the National Radiological Protection Board (NRPB), now the Radiation Protection Division of the Health Protection Agency, suggests that pregnant women should not be offered MRI in the first 3 months of pregnancy. These, in turn, can cause adverse effects that may be avoidable if the temperatures in the tissues do not exceed 38°C. On this basis, the NRPB concluded that until further information becomes available, pregnant women should not undergo MRI in the first 3 months of pregnancy unless the only reasonable alternative imaging method involves the use of x-ray procedures. |
| doi_str_mv | 10.1001/archderm.142.3.393-b |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_233117957</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>403283</ama_id><sourcerecordid>1012438611</sourcerecordid><originalsourceid>FETCH-LOGICAL-a175t-c783ef2b3dcfd4cbe02cf8c5f28df764a44b3c0d90880c36251149a4f4de652b3</originalsourceid><addsrcrecordid>eNo9kE1OwzAQhS0EEqVwACQWEfsE2-M0zhIVCpVagcqP2FkTxw6tmqTY6aI7DsEJOQmOCqxGmnnvjd5HyAWjCaOUXaHT76VxdcIETyCBHOLigAxYCjKGUcoPyYBSCnEus7djcuL9Kri4lHxApnOsGtMtdbQwvm2w0Saa1lgtmyqyrYueOqzC5jWamzU2bY3Rzdb1x0dnql6--_78WpjNendKjiyuvTn7nUPyMrl9Ht_Hs4e76fh6FiPL0i7WmQRjeQGltqXQhaFcW6lTy2Vps5FAIQrQtMyplFTDiKeMiRyFFaUJVQoYkst97sa1H1vjO7Vqt64JLxUHYCzL0yyIxF6kXeu9M1Zt3LJGt1OMqp6Z-mOmAjMFKjBTffb53oY1_jsEBS4BfgCP5WtY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>233117957</pqid></control><display><type>article</type><title>Magnetic Resonance Imaging for Stage IV Melanoma During Pregnancy—Reply</title><source>American Medical Association Journals</source><creator>Beyeler, Mirjam ; Hafner, Jürg</creator><creatorcontrib>Beyeler, Mirjam ; Hafner, Jürg</creatorcontrib><description>In the United Kingdom, the National Radiological Protection Board (NRPB), now the Radiation Protection Division of the Health Protection Agency, suggests that pregnant women should not be offered MRI in the first 3 months of pregnancy. These, in turn, can cause adverse effects that may be avoidable if the temperatures in the tissues do not exceed 38°C. On this basis, the NRPB concluded that until further information becomes available, pregnant women should not undergo MRI in the first 3 months of pregnancy unless the only reasonable alternative imaging method involves the use of x-ray procedures.</description><identifier>ISSN: 0003-987X</identifier><identifier>ISSN: 2168-6068</identifier><identifier>EISSN: 1538-3652</identifier><identifier>EISSN: 2168-6084</identifier><identifier>DOI: 10.1001/archderm.142.3.393-b</identifier><language>eng</language><publisher>Chicago: American Medical Association</publisher><subject>Magnetic fields ; NMR ; Nuclear magnetic resonance ; Pregnancy ; Radiation protection ; Skin cancer</subject><ispartof>Archives of dermatology (1960), 2006-03, Vol.142 (3), p.393-403</ispartof><rights>Copyright American Medical Association Mar 2006</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jamadermatology/articlepdf/10.1001/archderm.142.3.393-b$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/archderm.142.3.393-b$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,314,777,781,3327,27905,27906,76238,76241</link.rule.ids></links><search><creatorcontrib>Beyeler, Mirjam</creatorcontrib><creatorcontrib>Hafner, Jürg</creatorcontrib><title>Magnetic Resonance Imaging for Stage IV Melanoma During Pregnancy—Reply</title><title>Archives of dermatology (1960)</title><description>In the United Kingdom, the National Radiological Protection Board (NRPB), now the Radiation Protection Division of the Health Protection Agency, suggests that pregnant women should not be offered MRI in the first 3 months of pregnancy. These, in turn, can cause adverse effects that may be avoidable if the temperatures in the tissues do not exceed 38°C. On this basis, the NRPB concluded that until further information becomes available, pregnant women should not undergo MRI in the first 3 months of pregnancy unless the only reasonable alternative imaging method involves the use of x-ray procedures.</description><subject>Magnetic fields</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Pregnancy</subject><subject>Radiation protection</subject><subject>Skin cancer</subject><issn>0003-987X</issn><issn>2168-6068</issn><issn>1538-3652</issn><issn>2168-6084</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNo9kE1OwzAQhS0EEqVwACQWEfsE2-M0zhIVCpVagcqP2FkTxw6tmqTY6aI7DsEJOQmOCqxGmnnvjd5HyAWjCaOUXaHT76VxdcIETyCBHOLigAxYCjKGUcoPyYBSCnEus7djcuL9Kri4lHxApnOsGtMtdbQwvm2w0Saa1lgtmyqyrYueOqzC5jWamzU2bY3Rzdb1x0dnql6--_78WpjNendKjiyuvTn7nUPyMrl9Ht_Hs4e76fh6FiPL0i7WmQRjeQGltqXQhaFcW6lTy2Vps5FAIQrQtMyplFTDiKeMiRyFFaUJVQoYkst97sa1H1vjO7Vqt64JLxUHYCzL0yyIxF6kXeu9M1Zt3LJGt1OMqp6Z-mOmAjMFKjBTffb53oY1_jsEBS4BfgCP5WtY</recordid><startdate>20060301</startdate><enddate>20060301</enddate><creator>Beyeler, Mirjam</creator><creator>Hafner, Jürg</creator><general>American Medical Association</general><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20060301</creationdate><title>Magnetic Resonance Imaging for Stage IV Melanoma During Pregnancy—Reply</title><author>Beyeler, Mirjam ; Hafner, Jürg</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a175t-c783ef2b3dcfd4cbe02cf8c5f28df764a44b3c0d90880c36251149a4f4de652b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Magnetic fields</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Pregnancy</topic><topic>Radiation protection</topic><topic>Skin cancer</topic><toplevel>online_resources</toplevel><creatorcontrib>Beyeler, Mirjam</creatorcontrib><creatorcontrib>Hafner, Jürg</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Archives of dermatology (1960)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Beyeler, Mirjam</au><au>Hafner, Jürg</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Magnetic Resonance Imaging for Stage IV Melanoma During Pregnancy—Reply</atitle><jtitle>Archives of dermatology (1960)</jtitle><date>2006-03-01</date><risdate>2006</risdate><volume>142</volume><issue>3</issue><spage>393</spage><epage>403</epage><pages>393-403</pages><issn>0003-987X</issn><issn>2168-6068</issn><eissn>1538-3652</eissn><eissn>2168-6084</eissn><abstract>In the United Kingdom, the National Radiological Protection Board (NRPB), now the Radiation Protection Division of the Health Protection Agency, suggests that pregnant women should not be offered MRI in the first 3 months of pregnancy. These, in turn, can cause adverse effects that may be avoidable if the temperatures in the tissues do not exceed 38°C. On this basis, the NRPB concluded that until further information becomes available, pregnant women should not undergo MRI in the first 3 months of pregnancy unless the only reasonable alternative imaging method involves the use of x-ray procedures.</abstract><cop>Chicago</cop><pub>American Medical Association</pub><doi>10.1001/archderm.142.3.393-b</doi><tpages>11</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0003-987X |
| ispartof | Archives of dermatology (1960), 2006-03, Vol.142 (3), p.393-403 |
| issn | 0003-987X 2168-6068 1538-3652 2168-6084 |
| language | eng |
| recordid | cdi_proquest_journals_233117957 |
| source | American Medical Association Journals |
| subjects | Magnetic fields NMR Nuclear magnetic resonance Pregnancy Radiation protection Skin cancer |
| title | Magnetic Resonance Imaging for Stage IV Melanoma During Pregnancy—Reply |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T00%3A58%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Magnetic%20Resonance%20Imaging%20for%20Stage%20IV%20Melanoma%20During%20Pregnancy%E2%80%94Reply&rft.jtitle=Archives%20of%20dermatology%20(1960)&rft.au=Beyeler,%20Mirjam&rft.date=2006-03-01&rft.volume=142&rft.issue=3&rft.spage=393&rft.epage=403&rft.pages=393-403&rft.issn=0003-987X&rft.eissn=1538-3652&rft_id=info:doi/10.1001/archderm.142.3.393-b&rft_dat=%3Cproquest_cross%3E1012438611%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=233117957&rft_id=info:pmid/&rft_ama_id=403283&rfr_iscdi=true |